TNF-alpha and insulin-resistance: metabolic effects of in vivo therapeutic blockade
Insulin resistance is a key pathophysiologic feature of obesity, type 2 diabetes mellitus and prediabetic states (impaired fasting glucose, impaired glucose tolerance). TNF-α, a proinflammatory cytokine, plays an important role in the pathogenesis of insulin resistance associated with inflammation d...
Main Author: | F. Ursini |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-06-01
|
Series: | Reumatismo |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/449 |
Similar Items
-
New Insights on the Effect of TNF Alpha Blockade by Gene Silencing in Noise-Induced Hearing Loss
by: Janaína C. Rodrigues, et al.
Published: (2020-04-01) -
Are there any positive effects of TNF-alpha blockers on bone metabolism?
by: A. Sulli, et al.
Published: (2011-09-01) -
In Vivo Evaluation of TNF-Alpha in the Lungs of Patients Affected by Sarcoidosis
by: Filippo Galli, et al.
Published: (2015-01-01) -
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
by: Florie Bertrand, et al.
Published: (2017-12-01) -
In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice
by: Shi Q, et al.
Published: (2018-01-01)